Medicare Enrolled
Dr. Frank Huang, MD
Internal Medicine · Lodi, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Huang from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Huang?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Huang
Dr. Frank Huang is an internal medicine specialist in Lodi, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Huang performed 733 Medicare services across 427 unique beneficiaries.
Between the years covered by Open Payments, Dr. Huang received a total of $16,295 from 94 pharmaceutical and/or device companies across 781 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Huang is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 42% volume in CA
$16,295 industry payments
Medicare Practice Summary
Medicare Utilization ↗733
Medicare services
Top 42% in CA for internal medicine
427
Unique beneficiaries
$85
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~39 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
490 | $95 | $280 |
| Wound tissue removal, 20 sq cm or less This procedure involves the removal of tissue from a wound area measuring 20 square centimeters or less. |
83 | $28 | $87 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
69 | $125 | $360 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
53 | $10 | $21 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $63 | $198 |
| New patient office visit, complex (60-74 min) | 17 | $171 | $476 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,295
Total received (2018-2024)
Avg $2,328/year across 7 years
Top 7% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
94
Companies
781
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,275 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,928
2023
$2,443
2022
$3,471
2021
$1,907
2020
$1,008
2019
$2,044
2018
$1,493
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
BIOTISSUE HOLDINGS INC.
$678
MDD US Operations, LLC
$568
Alexion Pharmaceuticals, Inc.
$277
Amgen Inc.
$261
SK Life Science, Inc.
$245
ABBVIE INC.
$216
ARGENX US, INC.
$146
Neurocrine Biosciences, Inc.
$136
UCB, Inc.
$133
Takeda Pharmaceuticals U.S.A., Inc.
$93
Novo Nordisk Inc
$86
MIMEDX Group, Inc.
$79
JAZZ PHARMACEUTICALS INC.
$77
Amneal Pharmaceuticals LLC
$77
Vanda Pharmaceuticals Inc.
$69
Lundbeck LLC
$58
Kyowa Kirin, Inc.
$57
Celgene Corporation
$57
Ascendis Pharma Inc
$55
MITSUBISHI TANABE PHARMA AMERICA, INC.
$51
Biogen, Inc.
$49
Boehringer Ingelheim Pharmaceuticals, Inc.
$48
Medtronic, Inc.
$45
Merz Pharmaceuticals, LLC
$45
Neurelis, Inc.
$43
Integra LifeSciences Corporation
$41
Genentech USA, Inc.
$34
BANNER LIFE SCIENCES, LLC
$32
Lilly USA, LLC
$28
Mannkind Corporation
$21
Octapharma USA, Inc.
$21
EMD Serono, Inc.
$20
Bayer Healthcare Pharmaceuticals Inc.
$20
NEUROPACE, INC.
$19
Dexcom, Inc.
$16
Aucta Pharmaceuticals, Inc.
$14
SCILEX PHARMACEUTICALS INC.
$14
Top 3 companies account for 38.8% of 2024 payments
All-time payments by company (2018-2024) ›
BioTissue Holdings, Inc.
$999
BIOTISSUE HOLDINGS, INC.
$942
Alexion Pharmaceuticals, Inc.
$718
GENZYME CORPORATION
$696
BIOTISSUE HOLDINGS INC.
$678
UCB, Inc.
$644
MDD US Operations, LLC
$643
SANOFI-AVENTIS U.S. LLC
$640
Amgen Inc.
$617
ACADIA Pharmaceuticals Inc
$592
ABBVIE INC.
$575
SK Life Science, Inc.
$562
Boehringer Ingelheim Pharmaceuticals, Inc.
$538
Novo Nordisk Inc
$436
Neurocrine Biosciences, Inc.
$393
Lilly USA, LLC
$385
Smith+Nephew, Inc.
$373
Amneal Pharmaceuticals LLC
$360
AstraZeneca Pharmaceuticals LP
$293
Janssen Pharmaceuticals, Inc
$283
ARGENX US, INC.
$206
Lundbeck LLC
$184
Corcept Therapeutics
$168
Adamas Pharmaceuticals, Inc.
$164
Avanir Pharmaceuticals, Inc.
$162
Biogen, Inc.
$139
Takeda Pharmaceuticals U.S.A., Inc.
$139
Genentech USA, Inc.
$129
Mannkind Corporation
$128
Merck Sharp & Dohme Corporation
$121
EMD Serono, Inc.
$118
AbbVie Inc.
$108
Medline Industries, Inc.
$102
MannKind Corporation
$101
Horizon Therapeutics plc
$101
JAZZ PHARMACEUTICALS INC.
$99
ORGANOGENESIS INC.
$98
Merz Pharmaceuticals, LLC
$98
Sunovion Pharmaceuticals Inc.
$93
Medtronic, Inc.
$92
TEI Medical Inc.
$89
Ascendis Pharma Inc
$88
Melinta Therapeutics, Inc.
$87
Neurelis, Inc.
$86
Kerecis Limited
$86
ACELL, INC.
$86
EISAI INC.
$85
Eisai Inc.
$85
Amniox Medical, Inc.
$82
Supernus Pharmaceuticals, Inc.
$81
Kyowa Kirin, Inc.
$80
MIMEDX Group, Inc.
$79
Integra LifeSciences Corporation
$77
Novartis Pharmaceuticals Corporation
$77
Vanda Pharmaceuticals Inc.
$69
Shire North American Group Inc
$66
Catalyst Pharmaceuticals, Inc.
$61
Becton, Dickinson and Company
$58
Celgene Corporation
$57
Bayer HealthCare Pharmaceuticals Inc.
$51
MITSUBISHI TANABE PHARMA AMERICA, INC.
$51
Dexcom, Inc.
$50
DEXCOM, INC.
$43
Greenwich Biosciences, Inc.
$42
Xeris Pharmaceuticals, Inc.
$40
KCI USA, Inc.
$40
AbbVie, Inc.
$33
CeQur Corporation
$32
BANNER LIFE SCIENCES, LLC
$32
PORTOLA PHARMACEUTICALS, INC.
$26
Medtronic USA, Inc.
$26
Tandem Diabetes Care, Inc.
$25
Exeltis, USA Inc.
$25
GE HealthCare
$23
Osiris Therapeutics Inc.
$23
GE HEALTHCARE
$22
Resmed Corp
$22
Cala Health, Inc.
$21
Acorda Therapeutics, Inc
$21
Octapharma USA, Inc.
$21
Akcea Therapeutics, Inc.
$21
Bayer Healthcare Pharmaceuticals Inc.
$20
IMPEL PHARMACEUTICALS INC.
$19
Silk Road Medical, Inc.
$19
Radius Health, Inc.
$19
NEUROPACE, INC.
$19
Grifols USA, LLC
$17
Biohaven Pharmaceutical Holding Company Ltd.
$16
TISSUETECH, INC.
$15
Aucta Pharmaceuticals, Inc.
$14
SCILEX PHARMACEUTICALS INC.
$14
Averitas Pharma Inc.
$13
Banner Life Sciences, LLC
$13
PFIZER INC.
$13
Top 3 companies account for 16.3% of all-time payments
Associated products mentioned in payments ›
ACTIV.A.C. · ACTIVA · ADUHELM · AFINITOR · AFREZZA · AIR 11 · ANDEXXA · APTIOM · AUBAGIO · Aimovig · Androgel · Apligraf · BAFIERTAM · BAQSIMI · BD Nano · BD Nano 2nd Gen Pen Needle · BOTOX · BRILINTA · Baxdela · Briviact · CALA KIQ · CeQur Simplicity · Crysvita · DALVANCE · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · DUOPA · Dayvigo · Dermatology and Wound Care · Dexcom G6 Transmitter · EMGALITY · ENROUTE Transcarotid Neuroprotection System · EPIDIOLEX · Enspryng · Epidiolex · FARXIGA · FYCOMPA · Fintepla · Fycompa · GILENYA · GOCOVRI · GRAFIX PL · GRAFIX/GRAFIXPL/STRAVIX · GVOKE PFS · Gamunex-C · Gocovri · Grafix XC · HETLIOZ · HYQVIA · INBRIJA · INGREZZA · INVOKANA · Integra · JANUVIA · JARDIANCE · KYNMOBI · Kerecis Omega3 SurgiClose · Kerendia · Korlym · LANTUS · LEMTRADA · LEQEMBI · MAVENCLAD · MINIMED 770G · MINIMED 780G · Mavenclad · Motpoly XR · NATPARA · NATPARA (PARATHYROID HORMONE) · NEOX · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · Ocrevus · Ocrevus Zunovo · Ongentys · Ozempic · PANZYGA · PONVORY · PRIMATRIX · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · QUTENZA · RADICAVA · REXULTI · REYVOW · RNS Neurostimulator Kit · RYBELSUS · RYTARY · Rybelsus · SKYTROFA · SOLIQUA · SOLIQUA 100/33 · SOLIRIS · STEGLATRO · STRENSIQ · SYNTHROID · Santyl · Soliris · Stravix · Strensiq · TCC-EZ · TEFLARO · TEGSEDI · TEPEZZA · TOUJEO · TRADJENTA · TROKENDI XR · TYSABRI · Trintellix · Trudhesa · Tymlos · UBRELVY · ULTOMIRIS · UPLIZNA · V.A.C. DERMATAC · VALTOCO · VYEPTI · VYVGART · VYVGART HYTRULO · Victoza · Vimpat · XARELTO · XCOPRI · Xeomin · ZEPOSIA · ZTLido · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 7% for internal medicine in CA.
Geographic Context
Internal medicine physicians within 10 mi
208
Per 100K population
26.4
County median income
$88,531
Nearest hospital
ADVENTIST HEALTH LODI MEMORIAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Huang is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 7% of CA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Huang experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Huang performed 490 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Huang receive payments from pharmaceutical companies?
Yes. Dr. Huang received a total of $16,295 from 94 companies across 781 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Huang's costs compare to other internal medicine physicians in Lodi?
Dr. Huang's average Medicare payment per service is $85. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Huang) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Lodi
Browse internal medicine physicians in Lodi ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
BioTissue Holdings, Inc. Payments to Doctors
See all physicians who received payments from BioTissue Holdings, Inc.
By company
BIOTISSUE HOLDINGS, INC. Payments to Doctors
See all physicians who received payments from BIOTISSUE HOLDINGS, INC.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology